These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25814623)

  • 21. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duchenne muscular dystrophy: the effect of glucocorticoids on ventilator use and ambulation.
    Bach JR; Martinez D; Saulat B
    Am J Phys Med Rehabil; 2010 Aug; 89(8):620-4. PubMed ID: 20647779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed enhancement cardiac magnetic resonance imaging in a patient with Duchenne muscular dystrophy.
    Guillaume MD; Phoon CK; Chun AJ; Srichai MB
    Tex Heart Inst J; 2008; 35(3):367-8. PubMed ID: 18941638
    [No Abstract]   [Full Text] [Related]  

  • 24. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy.
    Tsuda T
    Methods Mol Biol; 2018; 1687():19-28. PubMed ID: 29067653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.
    Villa CR; Kaddourah A; Mathew J; Ryan TD; Wong BL; Goldstein SL; Jefferies JL
    Neuromuscul Disord; 2016 Oct; 26(10):637-642. PubMed ID: 27542440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily or alternative, that is the question: steroid therapy for Duchenne muscular dystrophy patients.
    Liang WC; Nishino I
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):591. PubMed ID: 23355805
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study.
    Mavrogeni S; Tzelepis GE; Athanasopoulos G; Maounis T; Douskou M; Papavasiliou A; Cokkinos DV
    Chest; 2005 Jan; 127(1):143-8. PubMed ID: 15653975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial late enhancement in Duchenne and Becker individuals in the clinical milieu.
    Giglio V; Camastra G; Ansalone G
    J Am Coll Cardiol; 2007 Nov; 50(20):2019-20; author reply 2020. PubMed ID: 17996572
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy.
    Yoon SH; Chen J; Grynpas MD; Mitchell J
    Bone; 2016 Sep; 90():168-80. PubMed ID: 27373502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach.
    Yilmaz A; Gdynia HJ; Baccouche H; Mahrholdt H; Meinhardt G; Basso C; Thiene G; Sperfeld AD; Ludolph AC; Sechtem U
    J Cardiovasc Magn Reson; 2008 Nov; 10(1):50. PubMed ID: 18983659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMR detects subclinical cardiomyopathy in mother-carriers of Duchenne and Becker muscular dystrophy.
    Mavrogeni S; Bratis K; Papavasiliou A; Skouteli E; Karanasios E; Georgakopoulos D; Kolovou G; Papadopoulos G
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):526-8. PubMed ID: 23579015
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Glemser PA; Jaeger H; Nagel AM; Ziegler AE; Simons D; Schlemmer HP; Lehmann-Horn F; Jurkat-Rott K; Weber MA
    Acta Myol; 2017 Mar; 36(1):2-13. PubMed ID: 28690388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy.
    Mavrogeni S; Papavassiliou A; Cokkinos DV
    Int J Cardiol; 2009 Mar; 132(3):e123-4. PubMed ID: 18063150
    [No Abstract]   [Full Text] [Related]  

  • 36. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study.
    Li W; Zheng Y; Zhang W; Wang Z; Xiao J; Yuan Y
    Neuromuscul Disord; 2015 May; 25(5):375-80. PubMed ID: 25701397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI.
    Yilmaz A; Gdynia HJ; Ludolph AC; Klingel K; Kandolf R; Sechtem U
    Circulation; 2010 Mar; 121(10):e237-9. PubMed ID: 20231539
    [No Abstract]   [Full Text] [Related]  

  • 38. Hereditary muscular dystrophies and the heart.
    Hermans MC; Pinto YM; Merkies IS; de Die-Smulders CE; Crijns HJ; Faber CG
    Neuromuscul Disord; 2010 Aug; 20(8):479-92. PubMed ID: 20627570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.
    Silva MC; Meira ZM; Gurgel Giannetti J; da Silva MM; Campos AF; Barbosa Mde M; Starling Filho GM; Ferreira Rde A; Zatz M; Rochitte CE
    J Am Coll Cardiol; 2007 May; 49(18):1874-9. PubMed ID: 17481447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?
    Thomas TO; Jefferies JL; Lorts A; Anderson JB; Gao Z; Benson DW; Hor KN; Cripe LH; Urbina EM
    Pediatr Cardiol; 2015 Mar; 36(3):561-8. PubMed ID: 25399404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.